Clinical Trials Directory

Trials / Conditions / Squamous Cell Non-small Cell Lung Cancer

Squamous Cell Non-small Cell Lung Cancer

13 registered clinical trials studyying Squamous Cell Non-small Cell Lung Cancer — 5 currently recruiting.

StatusTrialSponsorPhase
RecruitingA Study of ZW251 in Participants With Advanced Solid Tumors
NCT07164313
Zymeworks BC Inc.Phase 1
RecruitingA Study to Assess Adverse Events and Change in Disease Activity of Intravenously (IV) Infused ABBV-324 in Adul
NCT06858813
AbbViePhase 1
Not Yet RecruitingEfficacy and Safety of JMT101 Combined Wth Docetaxel / HB1801 in Patients With Squamous Cell Non-Small Cell Lu
NCT06319313
Shanghai JMT-Bio Inc.Phase 2 / Phase 3
RecruitingNeoadjuvant Therapy of Sintilimab Combined With Chemotherapy for Resectable Squamous Cell NSCLC（neoSCORE Ⅱ）
NCT05429463
Second Affiliated Hospital, School of Medicine, Zhejiang UniversityPhase 3
UnknownHLX35(EGFR×4-1BB Bispecific) in Patients With Advanced or Metastatic Solid Tumors
NCT05360381
Shanghai Henlius BiotechPhase 1
TerminatedA Study of Bemarituzumab Monotherapy and Combination With Other Anti-cancer Therapy in SqNSCLC With FGFR2b Ove
NCT05267470
AmgenPhase 1
RecruitingGI-101/GI-101A as a Single Agent or in Combination With Pembrolizumab or Lenvatinib in Advanced Solid Tumors
NCT04977453
GI Innovation, Inc.Phase 1 / Phase 2
TerminatedSCT-I10A or Placebo Plus Docetaxel With Previously Treated Squamous Cell Non-small Cell Lung Cancer
NCT04171284
Sinocelltech Ltd.Phase 3
TerminatedRogaratinib in Patients With Advanced Pretreated Squamous-cell Non-small Cell Lung Cancer (SQCLC)
NCT03762122
Swiss Cancer InstitutePhase 2
CompletedMGD019 DART® Protein in Unresectable/Metastatic Cancer
NCT03761017
MacroGenicsPhase 1
CompletedA Study of BIND-014 (Docetaxel Nanoparticles for Injectable Suspension) as Second-line Therapy for Patients Wi
NCT02283320
BIND TherapeuticsPhase 2
CompletedStudy of Nivolumab (BMS-936558) in Patients With Advanced or Metastatic Squamous Cell Nonsmall-cell Lung Cance
NCT01721759
Bristol-Myers SquibbPhase 2
CompletedStudy of BMS-936558 (Nivolumab) Compared to Docetaxel in Previously Treated Advanced or Metastatic Squamous Ce
NCT01642004
Bristol-Myers SquibbPhase 3